NZ584656A - Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer - Google Patents
Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancerInfo
- Publication number
- NZ584656A NZ584656A NZ584656A NZ58465608A NZ584656A NZ 584656 A NZ584656 A NZ 584656A NZ 584656 A NZ584656 A NZ 584656A NZ 58465608 A NZ58465608 A NZ 58465608A NZ 584656 A NZ584656 A NZ 584656A
- Authority
- NZ
- New Zealand
- Prior art keywords
- mtdna
- cancer
- mitochondrial dna
- residues
- detection
- Prior art date
Links
- 206010051403 Mitochondrial DNA deletion Diseases 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 108020005196 Mitochondrial DNA Proteins 0.000 abstract 6
- 239000012472 biological sample Substances 0.000 abstract 3
- 238000012217 deletion Methods 0.000 abstract 2
- 230000037430 deletion Effects 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US263707P | 2007-11-09 | 2007-11-09 | |
| PCT/CA2008/001956 WO2009059414A1 (en) | 2007-11-09 | 2008-11-10 | Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ584656A true NZ584656A (en) | 2012-08-31 |
Family
ID=40625325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ584656A NZ584656A (en) | 2007-11-09 | 2008-11-10 | Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US20100311057A1 (enExample) |
| EP (2) | EP3409793A1 (enExample) |
| JP (1) | JP5481383B2 (enExample) |
| KR (1) | KR101644661B1 (enExample) |
| CN (1) | CN101883864B (enExample) |
| AU (1) | AU2008324675B2 (enExample) |
| CA (1) | CA2704361C (enExample) |
| NZ (1) | NZ584656A (enExample) |
| WO (1) | WO2009059414A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011147096A1 (en) * | 2010-05-28 | 2011-12-01 | Biomerieux | Method and kit for discriminating between breast cancer and benign breast disease |
| CN107604061B (zh) * | 2017-08-31 | 2021-02-02 | 中国科学院北京基因组研究所 | 线粒体-细胞核dna甲基化联合位点的筛选方法和应用 |
| WO2024130647A1 (zh) * | 2022-12-22 | 2024-06-27 | 中国科学院广州生物医药与健康研究院 | 分离的环状rna及其在预防和治疗肺癌中的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| DE19653439A1 (de) * | 1996-12-20 | 1998-07-02 | Svante Dr Paeaebo | Verfahren zur direkten, exponentiellen Amplifikation und Sequenzierung von DNA Molekülen und dessen Anwendung |
| US6472378B2 (en) * | 1998-08-31 | 2002-10-29 | Pro-Neuron, Inc. | Compositions and methods for treatment of mitochondrial diseases |
| US20050026167A1 (en) * | 2001-06-11 | 2005-02-03 | Mark Birch-Machin | Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
| WO2002101086A2 (en) * | 2001-06-11 | 2002-12-19 | 1304854 Ontario Ltd. | Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
| EP1694695A4 (en) * | 2003-12-11 | 2007-10-31 | 1304854 Ontario Ltd | COMPLETE MITOCHONDRIAL GENOME SEQUENCES AS A DIAGNOSTIC TOOL FOR MEDICAL SCIENCES |
| WO2006111029A1 (en) * | 2005-04-18 | 2006-10-26 | Genesis Genomics Inc. | Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| AU2007359381B2 (en) * | 2007-09-26 | 2015-06-18 | Mitomics Inc. | 3.4 kb mitochondrial DNA deletion for use in the detection of cancer |
-
2008
- 2008-11-10 EP EP18160726.8A patent/EP3409793A1/en not_active Withdrawn
- 2008-11-10 NZ NZ584656A patent/NZ584656A/xx not_active IP Right Cessation
- 2008-11-10 EP EP08846547.1A patent/EP2220252B1/en not_active Not-in-force
- 2008-11-10 CN CN200880115243.2A patent/CN101883864B/zh not_active Expired - Fee Related
- 2008-11-10 JP JP2010532390A patent/JP5481383B2/ja not_active Expired - Fee Related
- 2008-11-10 CA CA2704361A patent/CA2704361C/en active Active
- 2008-11-10 US US12/742,032 patent/US20100311057A1/en not_active Abandoned
- 2008-11-10 WO PCT/CA2008/001956 patent/WO2009059414A1/en not_active Ceased
- 2008-11-10 AU AU2008324675A patent/AU2008324675B2/en not_active Ceased
- 2008-11-10 KR KR1020107012456A patent/KR101644661B1/ko not_active Expired - Fee Related
-
2013
- 2013-01-18 US US13/745,204 patent/US20130288243A1/en not_active Abandoned
-
2014
- 2014-09-17 US US14/489,119 patent/US20150004619A1/en not_active Abandoned
-
2016
- 2016-06-21 US US15/188,604 patent/US20160289772A1/en not_active Abandoned
-
2018
- 2018-04-06 US US15/947,192 patent/US10400290B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009059414A1 (en) | 2009-05-14 |
| CN101883864A (zh) | 2010-11-10 |
| CA2704361A1 (en) | 2009-05-14 |
| CN101883864B (zh) | 2014-02-12 |
| AU2008324675B2 (en) | 2015-04-23 |
| AU2008324675A1 (en) | 2009-05-14 |
| CA2704361C (en) | 2023-04-04 |
| US20100311057A1 (en) | 2010-12-09 |
| US20150004619A1 (en) | 2015-01-01 |
| EP3409793A1 (en) | 2018-12-05 |
| EP2220252B1 (en) | 2018-03-14 |
| JP2011502487A (ja) | 2011-01-27 |
| EP2220252A4 (en) | 2012-08-22 |
| US20130288243A1 (en) | 2013-10-31 |
| KR101644661B1 (ko) | 2016-08-01 |
| US20160289772A1 (en) | 2016-10-06 |
| US20180230549A1 (en) | 2018-08-16 |
| KR20100090702A (ko) | 2010-08-16 |
| JP5481383B2 (ja) | 2014-04-23 |
| US10400290B2 (en) | 2019-09-03 |
| EP2220252A1 (en) | 2010-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Treppendahl et al. | Predicting response to epigenetic therapy | |
| NZ596545A (en) | Improved detection of mage-a expression | |
| ATE534753T1 (de) | Zusammensetzungen und verfahren zur identifikation eines carbapenemase-gens | |
| PA8803901A1 (es) | Plantas y semillas de soja correspondientes al evento transgénico mon87701 y métodos de detección del mismo | |
| WO2011101728A3 (en) | Identification of source of dna samples | |
| WO2002022879A3 (en) | Detection of microsatellite instability and its use in diagnosis of tumors | |
| ATE454468T1 (de) | Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose | |
| WO2011132061A3 (en) | Methylation profiling of dna samples | |
| NZ584595A (en) | Methods for assaying melanocortin 1 receptor variants utilysing a mitochondrial DNA abberration which is a 3895 bp mtDNA deletion between nucleic acid 546 to 4444 of the mtDNA genome | |
| DE602004015626D1 (de) | Bei brustkrebs | |
| ATE426043T1 (de) | Verfahren zur identifizierung des brustkrebsrisikos | |
| WO2009057294A1 (ja) | 肝臓癌関連遺伝子、及び肝臓癌リスクの判定方法 | |
| KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도 | |
| GB0500996D0 (en) | Detection method and materials therefor | |
| MXPA05014220A (es) | Genes regulados en cancer ovarico como objetivos de pronostico y terapeuticos. | |
| NZ584656A (en) | Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer | |
| ATE461294T1 (de) | Brustkrebsdiagnoseverfahren | |
| WO2006081248A3 (en) | Cancer markers and detection methods | |
| WO2007001310A3 (en) | Methods and compositions for detecting rhinoviruses | |
| MX2010002993A (es) | Uso de clec1b para la determinacion de riesgo cardiovascular y trombotico. | |
| Primorac | The role of DNA technology in identification of skeletal remains discovered in mass graves | |
| MXPA02002507A (es) | Deteccion de alteraciones en un gen por pcr de largo alcance mediante el uso de elementos moviles humanos. | |
| GB2362212A (en) | Method for the identification and speciation of bacteria of the burkholderia cepacia complex | |
| WO2006131677A3 (fr) | Procede pour le diagnostic/pronostic du cancer du sein | |
| CY1113242T1 (el) | Μεθοδος και μεσα για ανιχνευση ανθρωπινων ιων θηλωματος |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 10 NOV 2015 BY BALDWINS INTELLECTUAL PROPERTY Effective date: 20130410 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2016 BY COMPUTER PACKAGES INC Effective date: 20151118 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2017 BY COMPUTER PACKAGES INC Effective date: 20170419 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2018 BY COMPUTER PACKAGES INC Effective date: 20180331 |
|
| ASS | Change of ownership |
Owner name: MDNA LIFE SCIENCES INC., 1209 ORANGE STREET, C, US Effective date: 20181218 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 NOV 2019 BY COMPUTER PACKAGES INC Effective date: 20190402 |
|
| LAPS | Patent lapsed |